logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
07/08/2025
Morgan Stanley lowered its target stock price for Yum Brands from $153 per share to $151 per share.
Latest
1 m ago
In the first of two pivotal Phase 3 trials targeting adult obese patients, oral GLP-1 drug orforglipron from Lai Company resulted in an average weight loss of up to 27.3 pounds.
1 m ago
In the first of two pivotal Phase 3 trials targeting adult obese patients, Orforglipron, an oral GLP-1 drug from Rely Company, achieved an average weight loss of up to 27.3 pounds.
1 m ago
Zhongguang Interconnection (688369.SH) plans to launch an employee stock ownership plan in 2025.
1 m ago
Robotech: The asking price for the transfer is 130.08 yuan per share.
1 m ago
Research shows that Lilly's first small molecule oral GLP-1RA drug, orforglipron, can reduce body weight by an average of 11.2%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.